New diabetes clinical trial: Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention

Published on: November 10, 2024 at 11:00PM
Conditions: Prediabetes / Type 2 Diabetes
Interventions: Drug: Metformin; Drug: GLP-1A; Dietary Supplement: MED
Sponsors: Stanford University
Not yet recruiting
https://ift.tt/M2YA9Xm